Using advanced imaging technologies as a means to enhance diagnostic accuracy was also of interest. Many HCPs pointed to the ...

Dr Wouter Vogel, radiation oncologist at the Netherlands Cancer Institute, explained that the reason the glands have gone ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] ...

It is the first centre to offer the tech in Melaka and Negeri Sembilan. Malaysia’s Mahkota Medical Centre has announced the ...

Illuccix, after radiolabelling with gallium-68, is indicated in France for the detection of prostate-specific membrane ...

New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent MELBOURNE, Australia, April 29, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: ...

Metastatic castration-resistant prostate cancer (mCRPC) is diagnosed by blood tests, imaging scans, and biopsies. Find out ...

The solid cash conversion allows Telix to internally fund organic growth and flexibility to pursue acquisitions. We expect the company to reinvest the majority of earnings into R&D. We forecast ...

Alexandre Mugwaneza, 69, visited his wife’s paternal cousin, who was battling prostate cancer. The image of a once-active man now frail and bedridden stayed with him. Though Mugwaneza felt fine, that ...

Pedro C. Barata, MD, MSc, discusses the use of darolutamide in patients with hormone-sensitive prostate cancer.

Alexander Kenigsberg, MD, discusses a new nonsurgical, robotic-focused ultrasound procedure for prostate cancer.